| Date Filed | Type | Description |
| 04/22/2020 |
15-12G/A
| Form 15-12G/A - Securities registration termination [Section 12(g)]: [Amend] |
| 03/09/2020 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 03/09/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/09/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/02/2020 |
DEFM14C
| Form DEFM14C - Definitive information statement relating to merger or acquisition: |
| 02/19/2020 |
PREM14C
| Form PREM14C - Preliminary information statements relating to merger or acquisition: |
| 02/19/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
| 08/30/2019 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 08/28/2019 |
4
| TAGLICH ROBERT (10% Owner) has filed a Form 4 on Icagen, Inc.|
Txns:
| Granted 71,428 warrants
@ $3.5, valued at
$250k
Granted 71,428 convertible preferred
@ $3.5, valued at
$250k
|
|
| 08/28/2019 |
4
| TAGLICH MICHAEL N (10% Owner) has filed a Form 4 on Icagen, Inc.|
Txns:
| Granted 71,428 warrants
@ $3.5, valued at
$250k
Granted 71,428 convertible preferred
@ $3.5, valued at
$250k
|
|
| 08/19/2019 |
10-Q
| Quarterly Report for the period ended June 30, 2019 |
| 08/14/2019 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 05/15/2019 |
10-Q
| Quarterly Report for the period ended March 31, 2019 |
| 05/02/2019 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 05/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2019 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 04/12/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
| 03/29/2019 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 01/11/2019 |
SC 13D/A
| TYSON TIMOTHY reports a 16.3% stake in ICAGEN, INC. |
| 12/28/2018 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
| 12/18/2018 |
PRE 14C
| Form PRE 14C - Other preliminary information statements: |
| 11/20/2018 |
8-K
| Amended existing or entered into new employment agreement with an officer |
| 11/19/2018 |
10-Q
| Quarterly Report for the period ended September 30, 2018 |
| 11/16/2018 |
4
| Cunningham, Richard Anthony (CEO) has filed a Form 4 on Icagen, Inc.|
Txns:
| Granted 535,000 options
@ $3.5, valued at
$1.9M
|
|
| 11/16/2018 |
4
| KABATZNIK CLIVE (Director) has filed a Form 4 on Icagen, Inc.|
Txns:
| Granted 25,000 options
@ $3.5, valued at
$87.5k
|
|
| 11/16/2018 |
4
| KORB MARK JOHN (CFO) has filed a Form 4 on Icagen, Inc.|
Txns:
| Granted 100,000 options
@ $3.5, valued at
$350k
|
|
| 11/16/2018 |
4
| Krafte Douglas (Chief Scientific Officer) has filed a Form 4 on Icagen, Inc.|
Txns:
| Granted 120,000 options
@ $3.5, valued at
$420k
|
|
| 11/16/2018 |
4
| Palmieri Vincent (Director) has filed a Form 4 on Icagen, Inc.|
Txns:
| Granted 25,000 options
@ $3.5, valued at
$87.5k
|
|
| 11/16/2018 |
4
| Roffman Edward (Director) has filed a Form 4 on Icagen, Inc.|
Txns:
| Granted 25,000 options
@ $3.5, valued at
$87.5k
|
|
| 11/16/2018 |
4
| TAGLICH MICHAEL N (10% Owner) has filed a Form 4 on Icagen, Inc.|
Txns:
| Granted 25,000 options
@ $3.5, valued at
$87.5k
|
|
| 11/16/2018 |
4
| TYSON TIMOTHY (10% Owner) has filed a Form 4 on Icagen, Inc.|
Txns:
| Granted 25,000 options
@ $3.5, valued at
$87.5k
Granted 100,000 options
@ $3.5, valued at
$350k
|
|
| 11/14/2018 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 10/18/2018 |
CT ORDER
| Form CT ORDER - Confidential treatment order: |
|